“Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients”, Reumatismo, vol. 75, no. 2, Jul. 2023, doi: 10.4081/reumatismo.2023.1544.